Maurice Blakemore

Maurice Blakemore, MBA, is an experienced oncology account manager currently serving at Immunocore, focusing on rare diseases. Previously held key account management roles at Harrow and Ocular Therapeutix, Inc., and served as a hematology clinical account specialist at Syneos Health. Notable experience also includes key account management at EUSA Pharma, where significant contributions were made during the Sylvant launch. Further background includes positions at US WorldMeds, Merz North America, Amgen, Daiichi Sankyo, and Ortho-McNeil Pharmaceutical, with a primary focus on oncology, hematology, and neuroscience. Maurice Blakemore holds an Executive MBA from Bellarmine University, a Master of Education from the University of Louisville, and a Bachelor of Education from the University of Tennessee at Martin.